Toxicological evaluation of arachidonic acid (ARA)-rich oil and docosahexaenoic acid (DHA)-rich oil

Food and Chemical Toxicology

Volumn 96, Issue , 2016, Pages 133-144

  Lewis, Kara D ^a   Huang, Weifeng ^b   Zheng, Xiaohui ^b   Jiang, Yue ^b   Feldman, Robin S ^a   Falk, Michael C ^a  

^a LSRO Solutions LLC   (United States)

^b Runke Bioengineering (Fujian) Co Ltd   (China)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Mortierella alpina; Schizochytrium sp.; Toxicity

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; DOCOSAHEXAENOIC ACID; TRIACYLGLYCEROL; FISH OIL;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHROMOSOME ABERRATION; DIETARY INTAKE; ERYTHROCYTE; GENE MUTATION; GENOTOXICITY; IN VITRO STUDY; METABOLIC ACTIVATION; MICRONUCLEUS TEST; MORTIERELLA ALPINA; NONHUMAN; PERIPHERAL LYMPHOCYTE; RAT; SCHIZOCHYTRIUM; THRAUSTOCHYTRIUM; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; EVALUATION STUDY; FEMALE; MUTAGEN TESTING; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; WISTAR RAT;

ANIMALS; ARACHIDONIC ACID; BODY WEIGHT; CHROMOSOME ABERRATIONS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; FISH OILS; MUTAGENICITY TESTS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 84982844876     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.07.026     Document Type: Article

References (44)

1. Abril, R., Garrett, J., Zeller, S.G., Sander, W.J., Mast, R.W., Safety assessment of DHA-rich microalgae from Schizochytrium sp. part V: target animal safety/toxicity study in growing swine. Regul. Toxicol. Pharmacol. 37 (2003), 73–82.
2. Al-Khudairy, L., Hartley, L., Clar, C., Flowers, N., Hooper, L., Rees, K., Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane. Database. Syst. Rev., 11, 2015, CD011094.
3. Arterburn, L.M., Oken, H.A., Hoffman, J.P., Bailey-Hall, E., Chung, G., Rom, D., Hamersley, J., McCarthy, D., Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food. Lipids 42 (2007), 1011–1024.
4. Bloch, M.H., Hannestad, J., Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol. Psychiatry 17 (2012), 1272–1282.
5. Burja, A.M., Radianingtyas, H., Windust, A., Barrow, C.J., Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production. Appl. Microbiol. Biotechnol. 72 (2006), 1161–1169.
6. Burns, R.A., Wibert, G.J., Diersen-Schade, D.A., Kelly, C.M., Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid: 3-month rat oral safety study with an in utero phase. Food Chem. Toxicol. 37 (1999), 23–36.
7. Casterton, P.L., Curry, L.L., Lina, B.A., Wolterbeek, A.P., Kruger, C.L., 90-day feeding and genotoxicity studies on a refined arachidonic acid-rich oil. Food Chem. Toxicol. 47 (2009), 2407–2418.
8. Dumancas, G.G., Murdianti, B.S., Lucas, E.A., Arachidonic Acid: Dietary Sources and General Functions. 2013, Nova Science Publishers, New York.
9. Dyall, S.C., Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front. Aging. Neurosci., 7, 2015, 52.
10. EFSA Panel on Dietetic Products, Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J. 10 (2012), 1–48.
11. European Commission, COMMISSION DECISION of 21 October 2009 Concerning the Extension of Uses of Algal Oil from the Micro-algae Ulkenia sp. as a Novel Food Ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (Notified under Document C(2009) 7932), 2009 J European Union 23.10.2009.
12. European Commission, COMMISSION DECISION of 22 October 2009 Concerning the Extension of Uses of Algal Oil from the Micro-algae Schizochytrium sp. as a Novel Food Ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (Notified under Document C(2009) 7933), 2009 J European Union 23.10.2009.
13. European Commission, Commission Implementation Decision (EU) 2015/545 of 31 March 2015 authorising the placing on the market oil from micro algae Schizochytrium sp. (ATCC PTA-9695) as a novel food ingredient under regulation (EC) No 258/97) of the European parliment and of the council (notified under document C(2015) 2082). J. Eur. Union L 90 (2015), 7–10.
14. Fedorova-Dahms, I., Marone, P.A., Bailey-Hall, E., Ryan, A.S., Safety evaluation of algal oil from Schizochytrium sp. Food Chem. Toxicol. 49 (2011), 70–77.
15. Fedorova-Dahms, I., Marone, P.A., Bauter, M., Ryan, A.S., Safety evaluation of DHA-rich algal oil from Schizochytrium sp. Food Chem. Toxicol. 49 (2011), 3310–3318.
16. Hammond, B.G., Mayhew, D.A., Kier, L.D., Mast, R.W., Sander, W.J., Safety assessment of DHA-rich microalgae from Schizochytrium sp. Regul. Toxicol. Pharmacol. 35 (2002), 255–265.
17. Harris, W.S., Baack, M.L., Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity. J. Perinatol. 35 (2015), 1–7.
18. Hempenius, R.A., Lina, B.A., Haggitt, R.C., Evaluation of a subchronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonic acid oil derived from Mortierella alpina in rats. Food Chem. Toxicol. 38 (2000), 127–139.
19. Hempenius, R.A., Van Delft, J.M., Prinsen, M., Lina, B.A., Preliminary safety assessment of an arachidonic acid-enriched oil derived from Mortierella alpina: summary of toxicological data. Food Chem. Toxicol. 35 (1997), 573–581.
20. Howlett, J., DHA - Rich Algal Oil from Schizochytrium sp. ONC - T18. A Submission to the UK Food Standards Agency Requesting Consideration of Substantial Equivalence to DHA - Rich Algal Oil from Schizochytrium sp. Authorised in Accordance with Regulation (EC) No 258/97, 2011, Ocean Nutrition Canada Limited, Dartmouth, NS.
21. Jedwards International, GRN 000146 Salmon Oil. 2004.
22. Jiao, J., Li, Q., Chu, J., Zeng, W., Yang, M., Zhu, S., Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 100 (2014), 1422–1436.
23. Kiso, Y., Pharmacology in health foods: effects of arachidonic acid and docosahexaenoic acid on the age-related decline in brain and cardiovascular system function. J. Pharmacol. Sci. 115 (2011), 471–475.
24. Kroes, R., Schaefer, E.J., Squire, R.A., Williams, G.M., A review of the safety of DHA45-oil. Food Chem. Toxicol. 41 (2003), 1433–1446.
25. Maehre, H.K., Jensen, I.J., Elvevoll, E.O., Eilertsen, K.E., Omega-3 fatty acids and cardiovascular diseases: effects, mechanisms and dietary relevance. Int. J. Mol. Sci. 16 (2015), 22636–22661.
26. McCann, J., Choi, E., Yamasaki, E., Ames, B.N., Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proceedings of the National Academy of Sciences of the United States of America, 72, 1975, 5135–5139.
27. Muggli, R., Fortified foods: a way to correct low intakes of EPA and DHA. Akoh, C.C., (eds.) Handbook of Functional Lipids, 2015, CRC Press, Boca Raton, 389–402.
28. Papanikolaou, Y., Brooks, J., Reider, C., Fulgoni, V.L. III, U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008. Nutr. J., 13, 2014, 31.
29. Ratledge, C., Fatty acid biosynthesis in microorganisms being used for single cell oil production. Biochimie 86 (2004), 807–815.
30. Rechenberg, K., Humphries, D., Nutritional interventions in depression and perinatal depression. Yale J. Biol. Med. 86 (2013), 127–137.
31. Sakuradani, E., Shimizu, S., Single cell oil production by Mortierella alpina. J. Biotechnol. 144 (2009), 31–36.
32. Salem, N. Jr., Eggersdorfer, M., Is the world supply of omega-3 fatty acids adequate for optimal human nutrition?. Curr. Opin. Clin. Nutr. Metab. Care 18 (2015), 147–154.
33. Schmitt, D., Tran, N., Peach, J., Bauter, M., Marone, P., Toxicologic evaluation of DHA-rich algal oil: genotoxicity, acute and subchronic toxicity in rats. Food Chem. Toxicol. 50 (2012), 3567–3576.
34. Stonehouse, W., Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients 6 (2014), 2730–2758.
35. Tai, E.K., Wang, X.B., Chen, Z.Y., An update on adding docosahexaenoic acid (DHA) and arachidonic acid (AA) to baby formula. Food Funct. 4 (2013), 1767–1775.
36. U.S.FDA, Agency Response Letter GRAS Notice No. GRN 000016: Menhaden Oil. 1999, FDA.
37. U.S.FDA, Agency response Letter to GRN 000041: DHASCO (Docosahexaenoic Acid-rich Single-cell Oil) and ARASECO (Arachidonic Acid-rich Single Cell Oil. 2000, FDA.
38. U.S.FDA, Agency Response Letter to GRN 000080: ARASCO Arachidonic-rich Single-cell Oil. 2001, FDA.
39. U.S.FDA, Agency Response Letter to GRN 000137: Algal Oil (Schysochytrium sp.). 2003, FDA.
40. U.S.FDA, Agency Response Letter to GRN 000094: Krill Oil. 2006, US Food and Drug Administration, Washington, DC.
41. U.S.FDA, Agency Response Letter GRAS Notice No. GRN 000319: Micro-algal Oil Ulkenia sp. SAM2179. 2010, FDA.
42. U.S.FDA, Agency Response Letter to GRN 000326: Arachidonic Acid Rich Oil from M. alpina Strain I49–N18. 2010, FDA.
43. U.S.FDA, Agency Response Letter GRAS Notice No. GRN 000553: Algal Oil (40% Docosahexaenoic Acid) Derived from Schizochytrium sp. 2014, FDA.
44. Wibert, G.J., Burns, R.A., Diersen-Schade, D.A., Kelly, C.M., Evaluation of single cell sources of docosahexaenoic acid and arachidonic acid: a 4-week oral safety study in rats. Food Chem. Toxicol. 35 (1997), 967–974.